Exercise program for children and adolescents with leukemia and lymphoma during treatment: A comprehensive review by Zucchetti, Giulia et al.
Received: 2 August 2017 Revised: 9 November 2017 Accepted: 14 November 2017
DOI: 10.1002/pbc.26924
Pediatric
Blood &
Cancer The American Society ofPediatric Hematology/Oncology
R EV I EW
Exercise program for children and adolescents with leukemia
and lymphoma during treatment: A comprehensive review
Giulia Zucchetti1 Francesca Rossi2 Carolina Chamorro Vina3
Nicoletta Bertorello1 Franca Fagioli1
1PediatricOncohematology, StemCell
Transplantation andCell TherapyDivision,
A.O.U. Città della Salute e della Scienza—Regina
Margherita Children'sHospital, Turin, Italy
2Rehabilitation Service, PublicHealth and
Pediatric SciencesDepartment, A.O.U. Città
della Salute e della Scienza—ReginaMargherita
ChildrenHospital, Turin, Italy
3PEERProgramCoordinator at theKidsCancer
Care of Alberta, Calgary, Alberta, Canada
Correspondence
GiuliaZucchetti, PediatricOncohematology,
StemCell TransplantationandCell Therapy
Division,A.O.U.Cittàdella Salute edella
Scienza—ReginaMargheritaChildren's
Hospital, Turin, Italy.
Email: giulia.zucchetti1@gmail.com
Abstract
An exercise program (EP) during cancer treatment seems to be a valid strategy against physiolog-
ical and quality-of-life impairments, but scientific evidence of benefits among pediatric patients is
still limited. This review summarizes the literature focused on randomized controlled trials of EP
offered to patients during leukemia and lymphoma treatment. Studies published up to June 2017
were selected frommultiple databases and assessed by three independent reviewers formethod-
ological validity. The review identified eight studies, but several types of bias have to be avoided
to provide evidence-based recommendations accessible to patients, families, and professionals.
K EYWORDS
exercise program, neurotoxicity of therapies, pediatric oncology, supportive care
1 INTRODUCTION
High-dose chemotherapy is the treatment strategy for most com-
mon childhood acute leukemia and lymphoma. Cyclophosphamide,
methotrexate (MTX), vincristine (VCR), and other chemotherapeutic
agents are responsible for several side effects on cognitive, neurolog-
ical, and motor functions, which negatively impact patients’ develop-
ment. Patients with leukemia and lymphoma are at risk for develop-
ing complications such as decreases in muscular strength, impaired
gross and fine motor skills, osteonecrosis, and fatigue.1,2 These out-
comes are evident at diagnosis and especially at an early stage of
treatment.3 A study by Akyay et al.4 highlighted that endurance,
strength, and functional mobility were poorer at the end of the induc-
tion phase compared with the period of the diagnosis. Symptoms such
as fatigue, low aerobic capacity, and lack of strengthmight persist after
patients’ complete treatment and lead survivors to be less active and
at greater risk of obesity than their healthy peers.5,6 For instance, due
to high doses of VCR and MTX, low exercise capacity is expected in
leukemia survivors.7 Moreover, muscle weakness and reduced mobil-
ity are always followed by a poor health-related quality of life (HRQoL)
and poor self-esteem and self-efficacy.3
Abbreviations: ALL, acute lymphoblastic leukemia; EP, exercise program; HRQoL,
health-related quality of life; MTX, methotrexate; RCTs, randomized controlled trials; VCR,
vincristine
Physical activity is a key factor in the development of healthy
children and has been suggested to improve cardiovascular capacity,
strength, and daily functioning in a wide range of pediatric chronic
diseases (e.g., juvenile idiopathic arthritis, cerebral palsy, and cystic
fibrosis).8 In healthy populations, research indicates that physical inac-
tivity is an independent risk factor for noncommunicable diseases such
as obesity, diabetes, cardiovascular disease, and cancer.8 Promoting
physical activity in childhood cancer patients and survivors is impor-
tant, as they are at a greater risk (compared to healthy children) of
developing a sedentary lifestyle and the associated comorbid condi-
tions. Published literature now supports the contention that partic-
ipation in an early individualized exercise program (EP) for patients
with cancer prevents or reduces some severe sequelae and muscle
toxicity.9 However, exercise benefits among cancer children and ado-
lescents continue to be underestimated.10–12
A recent review by Braam et al.13 considered six studies (both ran-
domized controlled trials [RCTs] and controlled clinical trials) on EP
among children and adolescents with cancer on and off treatment.
The review highlighted that some questions regarding exercise bene-
fits have remained open. First, very few RCTs of EP with young cancer
population have been carried out. RCTs are the most rigorous meth-
ods to determine whether a cause–effect relationship exists between
an intervention and an outcome. The paucity of these types of stud-
ies plus the small sample size did not allow researchers to provide any
solid evidence. Also, the specific features of these studies are still to
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be determined (e.g., timing and intensity). Braam et al.’s review has
proved very useful even if it does not limit its attention only to the
study of RCTs among patients with leukemia and lymphoma during
treatment. To date, there seems to be a lack of systematic reviews that
analyze the effect of RCTs on children and adolescents with leukemia
and lymphoma during treatment. It is important, as these patients
form the largest category of children and adolescents with oncologi-
cal diagnoses.14 Furthermore, patients with hematological cancer typ-
ically present more strength deficit or chemotherapy-induced periph-
eral neuropathy side effects than patients with other types of can-
cer such as brain or bone tumors.15 So, similar characteristics among
children and adolescents with leukemia and lymphoma make them a
homogenous group to create unique EP recommendations and their
rate of diagnosis permits enrollment of a large sample of patients. As
these patients have the highest survival rates and major late effects,
surveillance programs are recommended. Thus, concentrating on
patients undergoing treatment would allow the creation of an EP with
a preventionperspective by limiting several treatment late side effects.
Therefore, themain aim of this review is to summarize and describe
RCTs of EP carried out on children and adolescents with leukemia
and lymphoma during treatment, providing healthcare professionals
with a practical vision to enable them to recommend exercise to their
patients.
The secondary objective is to discuss their major biases and defi-
ciencies to propose valid insights for future trials with children and
adolescents.
2 METHODS
2.1 Eligibility criteria
This review only included RCTs of EP conducted with a control group
undergoing standard care.
Inclusion criteria were as follows: (1) RCT articles published until
June 2017, (2) patients with leukemia or lymphoma aged 0–18 years,
(3) EP offered within the cancer treatment protocol (also considering
the maintenance phase), and (4) articles focused on the effect of EP on
physical and/or psychosocial functions.
2.2 Data source and search strategy
Six biomedical databaseswereused as follows: PubMed, TheCochrane
Library, CINAHL, Scopus, PEDro, and PsycInfo. Manual searches
were also performed and further papers were found. To compile the
research array, the primary search terms “Leukemia” and “Lymphoma”
were combined with “Physical Exercise” and “Rehabilitation” (MeSH
termsor free-textwords). Someexamplesof full search strategieswere
as follows: “Lymphoma AND Motor Exercise,” limit: clinical trial and
age range 0–18 years (Figure 1).
2.3 Study selection
The full texts of articles that seemed tomeet the inclusion criteriawere
retrieved for further evaluation according to predefined criteria.
2.4 Data extraction
Eight studies met the inclusion criteria. After the search strategy,
two reviewers (G.Z. and F.R.) independently identified studies meeting
the inclusion criteria. Both authors resolved discrepancies by reach-
ing a consensus. In two cases, a third reviewer (C.C.V.) was needed;
we sought another opinion of the studies by Courneya et al. 16 and
Kauhanenet al.17; Courneyaet al.’s studywas thenexcluded16 because
the EP considered patients who were 18 years or older; and even
though the study results are ongoing, the Kauhanen et al.’s study was
included.17
The following data were extracted from each study: references,
method and design, sample, EP, control group program, outcomes and
possible adverse effects, evaluation tools, effects of EP on outcomes,
gaps, bias, and requirement (Supplementary Table S1).
3 SELECTED STUDIES ANALYSIS
A total of 31 papers were identified from the database and manual
search. Twenty-two manuscripts were excluded after evaluating the
abstract as they did not fit the search criteria and one was excluded
by consensus of researchers.16 Therefore, eight papers were included
in this review (Figure 1).
3.1 Method and design
The randomization process was adequately specified in five
studies17–21 and in three studies it remained unclear.22–24 Four
studies included patients during the maintenance phase18,22–24: two
studies indicated the timing as “after diagnosis”17,21 and in two studies
the treatment phase was not specified.19,20 Two studies measured
pre- and post-EP,18,24 four studies considered different measure-
ments during EP,19,20,22,23 and two studies had only a follow-up
measurement.17–21
F IGURE 1 Literature regarding RCTs for children and adolescents
with leukemia and lymphoma during treatment
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3.2 Sample
The sample size given in two studies was 14 patients22,23; other stud-
ies had samples of 28,18 29,19 34,17 41,23 51,21 and 68 patients.20
Most studies includedparticipants aged3–18years17–20,22–24 andonly
one study included patients aged 1–18 years.21 Five studies were car-
ried out with a sample taken exclusively from acute lymphoblastic
leukemia (ALL) patients18,23,24; one study included children with ALL
and other types of cancer outside the central nervous system (such as
lymphoma),17 another study considered solid tumors or acutemyeloid
leukemia,19 and one study considered patients with any type of child-
hoodmalignancy.20
3.3 Exclusion criteria
All the studies, except for one,22 highlighted the exclusion criteria.
3.4 Exercise program
Five studies included both supervised hospital-based programs and
home-based EPs,17–19,21,24 while home-based EPs were prescribed in
two studies.22,23 The duration of the studies varied from less than
1 month19 up to 2 years.21 The EP was based on aerobic train-
ing in most studies.17–19,22 Strength training was performed in three
studies18,21,24 and two studies prescribed stretching exercises.18,21
One study23 used a threshold device. Another study proposed com-
bined EP trainingwith a combination of cardiorespiratory and strength
exercises with psychosocial activities consisting of psychoeducation
and cognitive behavioral techniques.20
3.5 Control group program
In seven studies, children in the control group had to follow care as
usual.18–24 In one study, the control group received the general recom-
mendation to do 30min of exercise per day.17
3.6 Outcomes and possible adverse effects
Regarding the outcome measures, three studies examined cardiores-
piratory fitness18,22–24 while four examined flexibility.18,21,22,24 Three
studies measured muscle endurance19,22,23 and one study examined
strength.18 Two studies examined functional mobility18,19 and two
studies examined motor performance.17,21 Three studies analyzed
anthropometric factors17,21,22 and included variables such as body
composition and bonemineral density.21
Twostudies examined theamountof physical activity and sedentary
behavior.17,22 Three studies examined fatigue17,19,20 and three stud-
ies examinedHRQoL.18–20 Only one study examined psychosocial out-
comes such as behavioral problems, depressive symptoms, and self-
perception variables.20
Other outcome variables studied were as follows: the feasibility of
an EP intervention,19 adherence to exercise,18 the children's percep-
tionsof theactivities,17 sleepefficiency,19 food intake,22 and the child's
thoughts about disease.24
3.7 Evaluation tools
The “9 Min Run-Walk Test”18,22–24 and the “Progressive Aerobic Car-
diovascular Endurance Run (PACER)”22 examined cardiorespiratory
fitness. Goniometer and the “Sit It and Reach Test”22 examined flexi-
bility. “Push up Test,”22 “Digital Manometer,”23 and “Dynamometer”24
examined muscle endurance. The “Hand-Held Dynamometer” mea-
sured strength18 and the “Timed Up And Down Stairs Test” measured
functional mobility.18,24 The “Dutch Bayley Scales of Infant Devel-
opment” and the “Movement Assessment Battery for Children”17,21
examinedmotor performance. Anthropometric factorswere examined
usingbodymass index,musclemass,weight andheightmeasures, anda
dual energyX-ray absorptiometry.17,21,22 Theamountof physical activ-
ity and sedentary behavior was analyzed through two questionnaires
and a diary proposed by the authors.17 The “PedsQLMultidimensional
Fatigue Scale” and the “Fatigue Scale for Children with Cancer” exam-
ined fatigue.17,19,20,25 “PedsQL 4.0 Generic Core Scale”26 and the
“PedsQL 3.0 Cancer module”27 examined HRQoL. The “Child
Behaviour Checklist (CBCL)” and the “Youth Self-Report (YSR)”
analyzed behavioral issues.20 The “Children's Depression Inventory”
and the “Dutch versions of the Self Perception Profile” analyzed
depressive symptoms and self-perception, respectively.20 Feasibility
of an EP intervention was examined19 through a study checklist. Only
one study examined the adherence to the activity program through
the compilation of a log.18 Another study examined the children's
perception of the activities using an interview that includes open
questions.17
Sleep efficiency was examined with the “Daily Sleep Diary-
Parent,”19 and another study examined the food intake through a
record reviewed by phone.22 One study examined some information
about the child (such as age, gender, and thoughts about the disease)
by using a “Children's Identifying Information Form” drawn up by the
researchers24 (Supplementary Table S2).
3.8 Effects of EP on outcomes
The interventions had positive effects on cardiovascular variables,22,24
flexibility,18 muscle endurance/strength,23,24 functional mobility,18,24
motor performance,21 and long-term effects on anthropometric
factors,21 body composition, and bonemineral density.21 Other signifi-
cant effects describedwere sleep efficiency19 and the amount of phys-
ical activity and sedentary behavior.22 The EP intervention resulted
feasible during the inpatient phase for chemotherapy.19 Modest pos-
itive effect was observed in some HRQoL parent report variables.20
Effects on the adherence to exercise and on the children perception of
the activities were not possible to understand.17,18
3.9 Gaps, problems, and requirements
The main biases considered include method and design, sample, EP,
outcomes, evaluation tools, and effects of EP on outcomes.
There is a lack of RCTs with protocols that followed the method-
ological guidelines outlined in theCONSORT statement.28 Three stud-
ies did not blind the participants18,19,21 and in other three studies the
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randomization process was not clear or not reported.22–24 Also, one
study18 did not clearly report difference of measures at baseline. Mis-
takes were present in themissing data processing.21
Six studies have sample bias. Three studies17,23,24 did not report the
leukemia risk type. Other biaseswere the limitation of the age range of
patient groups,22 the lowage at the recruitment phase,21 and the small
sample size.20,22
Five studies had EP bias. One study18 described a personalized
individual home-based EP. Thus, children do not have the same EP
and some of the Frequency, Intensity, Time, and Type (FITT) princi-
ples varied among the participants. This choice reduced the possibil-
ity tomake transversal considerations on the effects of exercise on the
whole patient group. Furthermore, while the authors declared that the
EPwas age appropriate, they did not specify how theymet those crite-
ria. Another study19 did not use any tools such as daily activity logs to
report the adherence to the home-based EP, the timing of the EP inter-
ventionwas not specified, and the activitiesmade by the control group
were not clearly described. Also in this case, adherence to intervention
was assessed only in every third or fifth enrolled patient.
In one study,21 the intervention, timing, and duration of each exer-
cise session were not specified. In another study,23 the timing of the
assessments differed between the experimental and control groups
and the EPwas not supervised elsewhere.17
Outcomes were not identified as primary or secondary outcomes.
Multiple analyses of the same data created risks for false positive find-
ings. Analyses that were prespecified in the trial protocol (primary
outcomes) are much more reliable than those suggested by the data
(secondary outcomes), and therefore researchers should report which
analyses were prespecified.
Three studies have tools bias regarding an incomplete description
of assessment instruments18,24 and/or the utilization of a nonstan-
dardizedmeasurement scale.17
Five studies have problems concerning the effects of EP bias. In
three studies,19–21 the effectswere not differentiated according to the
type of cancer and in three studies the effects of EP on the outcomes
were not clearly described.21,22,24
4 BIAS SOLVING
The majority of the RCTs in this study had errors in the randomiza-
tion process. This makes it difficult to provide correct evidence about
the type of association between EP and outcomes. Randomized con-
trolled clinical trials represent the gold standard of research in health-
care interventions, although it could be difficult to meet all the crite-
ria proposed by the CONSORT statement.28 Blinding the population
that is receiving an EP in the same hospital might be almost impos-
sible. However, blinding the assessors can be a good start to make
assessmentmore objective. Sampling problems are a common bias due
to the low incidence of cancer in the pediatric population, the differ-
ent stages of development of children, and the different types of can-
cer. All these problems made the generalization of findings difficult in
pediatric oncology. Future RCTs should examine the effects of EP in a
large sample of childhood cancer leukemia and lymphoma subgroups
to make the results more exploitable by the professional community
and more tailored to specific types of patients. Multisite rather than
single center studies are highly recommended.
There was considerable evidence of heterogeneity on the type and
intensity of the EP among the selected studies, thus we were unable
to draw conclusions regarding the best EP. However, homogeneity can
be explained if we applied the principle of training. Because this review
focuses on a population that was on treatment and most of the inter-
ventions were about 3 or 4months long, the frequency, intensity, type,
and time proposed in the interventions make them appropriate if we
follow the progression and specificity principle. Fatigue, loss of muscle
mass, and deteriorating aerobic capacity are well-known side effects
of treatment. Thus, aerobic and strength training are present in most
of the interventions. Fromaprogression perspective of another impor-
tant training principle, low to moderate exercise intensity should be
considered appropriate as the population is on treatment and might
be deconditioning with other symptoms and side effects that might
limit the exercise intensity. Focus on longer studies (2–4 years) will
allow researchers to show different types of programs based on the
application of progression (principle of training). Another solution is
to start grouping patients with common side effects, instead of can-
cer type, such as decreased aerobic capacity, diminished ankle dorsi-
flexion, decrease in strength, and osteoporosis, and come up with dif-
ferent types of exercise guidelines that will be specifically tailored to a
pertinent side effect. Specific exercise guidelines for different types of
oncological diagnoses as well as different types of stage of treatment
and common side effects should always be performed worldwide as
already suggested byViña et al.8 These guidelineswill not only serve as
a tool for spreading the benefits of EP during the pediatric cancer jour-
ney but also establish, common criteria to prescribe EPs for childhood
cancer populations. The current state of published research suggests
that there is a pressing need to provide evidence-based guidelines for
those working with this population to promote exercise participation.
Finally, a combination of physical and psychosocial variables, both
objective and self-reported ones, would be the best strategy.
5 DISCUSSION
In conclusion, to date the effects of the interventions are still uncon-
vincing, which make it impossible to draw specific suggestions about
the optimal strategy to conduct EP. Although the studies presented in
this reviewwere RCTs, there is still toomuch variability among them in
terms of study design and intervention characteristics, so further prac-
tical suggestions aremandatory.
An imaginative solution could be the design of an EP to be used as
a “paradigm.” An EP paradigmwould allow professionals to follow pre-
cise standards of activities andprocedures both regarding themethod-
ology (i.e., randomization and participants) and the scheme and the
content of the EP. An EP paradigm should exist at least for the three
major categories of pediatric tumors such as hematological, solid, and
brainmalignancies. This paradigmcanalsobe constructedaroundcom-
mon types of side effects such as fatigue, decreased aerobic capac-
ity, peripheral neuropathy, and osteoporosis. Also the paradigm should
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also respond to the objectives of exercise training during different
stages of treatments and thus will help to create a sense of variability
and progression along different stages of treatments.
To achieve this arduous task, consideration should be given to the
approach of the International Study Group,29 a collaboration of pro-
fessionals from several countries to bring international agreement on
how to develop EP paradigm. It allows sharing of the same EP in sev-
eral centers, thus seeking to reach a multicenter consensus. Also, the
possibility to share epidemiological data on culturally diverse popu-
lations is undoubtedly another added value of this proposal. Despite
its ambitious nature and the awareness about pediatric recruitment
issues, the considerations on this proposal are encouraging. The study
of Soares-Miranda and colleagues30 in fact confirms the possibility to
invest in a specific and standardized program for a single tumor class,
which meets the quality criteria for RCTs (e.g., randomization, concur-
rent comparison group, blinded measurement). In fact, the proposed
EP paradigm for solid tumors is also able to reach the methodologi-
cal fulfillments necessary to support strong medical evidence. Specif-
ically, this study explored the beneficial effects of EP on the immune
system; it is very important because it allows new relevant insight
on the positive effects of EP on immune defense, which can play an
important role in tumor growth suppression. So, an EP paradigm that
respects RCTs criteria is a practicable route in the pediatric oncology
field.
Multicenter studies, in terms of both medical rehabilitation pro-
grams andmedicine sports program interventions, are needed to high-
light the unique and key role of physical exercise in pediatric oncol-
ogy care as preventive and supportive care for children and adolescent
patients receiving therapy andduring the stages of their cancer. Finally,
EPs presented in this reviewdid not present any important detrimental
effect on the health of participants. It is an important finding consid-
ering the American College of Sport Medicine call to avoid inactivity
in all forms of cancer, even in those with difficult treatment or prog-
nosis. Thus, doing regular exercise should be recommended instead of
bed rest or not performing any physical activity. At the same time, the
WorldHealthOrganization declares physical activity as a public health
priority. As researchers, we should focus on providing guidelines that
help practitioners to recommend exercise based on the evidence that
we have, and advancing this would be easy as soon as exercise start to
becomemore common in standard care.
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